Fibrocell Science Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$1.41 |
Market Cap |
$18.54 M |
Shares Outstanding |
9.76 M |
Public Float |
8.1 M |
Address |
405 Eagleview Boulevard Exton Pennsylvania 19341 United States |
Employees | - |
Website | http://www.fibrocell.com |
Updated | 07/08/2019 |
Fibrocell Science, Inc. is an autologous cell and gene therapy company, which engages in translating personalized biologics into medical breakthroughs for diseases affecting the skin and connective tissue. Its clinical and pre-clinical programs include treatments for restrictive burn scars, vocal cord scars, and acne scars. The company was founded on September 1, 2009 and is headquartered in Exton, PA. |